L8.2 Ischemic heart disease Flashcards

1
Q

How is coronary flow increased?

A
  • Prolonged diastole → increases oxygen supply to the heart (coronary blood travels with diastole)
  • Dilate coronary A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is O2 demand dependent on?

A
  • CO (workload)
  • Preload (compliance)
  • Afterload (resistance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Definition of angina?

A
  • Imbalance b/w o2 demand and supply
  • Insufficient O2 to meet cardiac demand (due to lack of perfusion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 3 types of angina?

A
  • Stable angina (classic)
    • Chest pain with exertion/stress (demands met at rest)
    • Associated with coronary A disease
  • Variant angina (vasospastic)
    • Coronary vasospasm at rest
    • Mediator unknown
      • Cannot treat well
  • Unstable angina (crescendo)
    • Angina at rest and with effort
    • Potential for thrombus formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features of stable angina?

A
  • Normally → dilation of A during exercise to increase flow to meet demands
  • Angina occurs due to → already dilated at rest, no reserve dilation (due to low compliance) during exercise
    • Increase O2 demands not met with increase BF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aims of prevention for stable angina?

A
  • Prevent attacks/relieve symptoms/prevent progression to MI
  • Use drugs to increase O2 supply (hard → cannot increase arteriole size) & decrease O2 demand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treating stable angina - by increase O2 supply

A
  • Dilate coronary A
    • Hard → may already be maximally dilated and has low compliance
  • Reduce HR
    • Longer diastole phase → coronary A have longer time to fill
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treating stable angina - by decreasing O2 demands

A
  • Decrease CO (ß-adrenoceptor antagonists/Ca channel blockers/ivabradine(targets HR specifically))
    • Decrease HR & SV
  • Reduce preload (nitrates)
    • Dilate veins/reduce venous return
  • Reduce afterload (Ca channel blockers)
    • Dilate arterioles, decrease resistance for heart to pump against
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of nitrates

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Features of Nitrate

A
  • Is usually a prodrug
  • Mimicks endogenous procress (releasing NO)
    • Guanylate cyclase → GTP into cGMP → MLC (myosin light chain) dephosphorylate form (unable to interact with actin) → vascular relaxation
  • Nitrates can affect all vessels
    • Predominant effect on the veins (decrease preload through vasodilations)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GTN

A
  • short acting
  • Routes of administration
    • Undergo significant first pass metabolism (cannot be taken orally)
    • Taken sublingually → to relieve acute attack
    • Transdermal patch → for prophylaxis (prevention)
    • I.v. → for emergency
  • Unstable drug
    • Cannot be stored in plastic (absorbed by plastic → decrease activity) and has to be stored in the dark
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Isosorbide dinitrate

A
  • longer acting
  • Used orally for anticipation of effort or prophylaxtically
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nitrate SE

A
  • Brief relaxation of gut/airways (not much clin significance)
  • Postural hypotension (form venous pooling)
  • Headache/flushing - from arterial dilations
  • Small reflex tachycardia
    • Usually used in combination with b-blockers or Ca channel blockers to minimise effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nitrate drug interactions

A
  • Viagra is a phosphodiesterase inhibitor
    • Phosphodiesterase breaks down cGMP
    • Viagra + GTN → significant cGMP levels → too much venousdilation → may have fatally low VR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does tolerance of nitrates develop

A
  1. Classic mechanism involves depletion of tissue thiols required for NO production from GTN
  2. Increase sensitivity of other constrictors (e.g. ANGII/A)
  3. Increase endothelial free radical production scavenging NO → reduce NO bioavailability
  4. Reduced acitivity of muscle mitochondrial enz → decrease NO production and increase free radicals

Tolerance develops with continuous use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can tolerance with nitrates be prevented/attenuated?

A
  • Need to maximise drug-free period (i.e. remove patch over night/period of non-exercise)
17
Q

Ca channel blockers

A
  • Used prophylactically
  • Blocks Ca entry into the heart via L-type channel blocking
    • Decrease HR → Increase supply
    • Decrease CO/SV/HR → decreases demands
      • Verapamil
  • Nifedipine → selective for vasculature
    • Leads to arterial dilation → reduce afterload and demands
18
Q

Mechanism of Ca channel blockers

A
  • *MLCK important for phosphorylation of MLC
19
Q

SE of verapamil and nifedipine

A

Verapamil

  • Constipation, flushing/headache/oedema (vasodilation)
  • Bradycardia, AV block (acts on heart)
  • NEVER taken with ß-blockers

Nifedipine

  • Flushing/headache/oedema
  • Hypotension (from arteriole dilations)
  • Reflextachycardia (from hypotension)
20
Q

B-blockers

A
  • Acts to block the effect of SNS
  • Receptors located on the SA, AV nodes → decrease HR/SV/CO
    • Decrease workload of heart
    • Increases O2 supply (from decrease HR)
  • First-line therapy for prophylaxis
    • Atenolol (selective ß1)
    • Propranolol (non-selective)
21
Q

Ivabradine

A
  • Selective for reducing HR (doesn’t have cardio-depressive effects)
  • Specific channels within SA node → I-f channel (which causes NA influx into cell)
    • Inhibition leads to increase time taken for AP to reach threshold → reduces HR
  • Disease-modifying by increasing O2 supply and decrease O2 (from decrease HR)
    • Reduces risk of MI, and need for revascularisation
    • No reduction if HR<70bpm
22
Q

Ivabradine SE

A
  • Channels also found in retina → brightness in visual fields
  • Conduction abnormalities
  • Long-term benefits/risks have been established
23
Q

Overview of the treatment for stable angina

A
24
Q

Treatment of variant angina

A
  • Treatment: GTN (Short acting)
    • To relieve vasospasm
    • Prophylaxis with dihydropyridine Ca channel blocker (i.e. Nifedipine)
    • Contra-indicated with ß-antagonist (potentially increase freq/severity of attacks)
25
Q

Treatment for unstable angina

A
  • Treatment same as classic angina
  • Include aspirin for prevention of thrombosis
26
Q

Risk factor reduction and prevention of heart diseases

A

Stop smoking

Increase physical activity & losing weight

Treat hypertension/dyslipidaemia/diabetes

27
Q

When is revascularisation used

A
  • When other treatments fails:
    • Percutaneous coronary intervention
    • Bypass graft